Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022

por Linger, Rachel M. A., Fadare, Joseph O., Shen, Ye, Van Winkle, Lon J.
Publicado 2023

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus

por Migdall-Wilson, Justine, Bates, Christine, Schlegel, Jennifer, Brandão, Luis, Linger, Rachel M. A., DeRyckere, Deborah, Graham, Douglas K.
Publicado 2012

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer

por Cummings, Christopher T., Linger, Rachel M.A., Cohen, Rebecca A., Sather, Susan, Kirkpatrick, Gregory D., Davies, Kurtis D., DeRyckere, Deborah, Earp, H. Shelton, Graham, Douglas K.
Publicado 2014

Mer or Axl Receptor Tyrosine Kinase Inhibition Promotes Apoptosis, Blocks Growth, and Enhances Chemosensitivity of Human Non-Small Cell Lung Cancer

por Linger, Rachel M.A., Cohen, Rebecca A., Cummings, Christopher T., Sather, Susan, Migdall-Wilson, Justine, Middleton, Deryck H.G., Lu, Xian, Barón, Anna E., Franklin, Wilbur A., Merrick, Daniel T., Jedlicka, Paul, DeRyckere, Deborah, Heasley, Lynn E., Graham, Douglas K.
Publicado 2012